Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-11 · accession 0001209191-21-064508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-15 | 2021-11-11 | NKTR | Brainard Diana | Dir | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
| D | 2021-11-15 | 2021-11-11 | NKTR | Brainard Diana | Dir | A - Grant | $0.00 | +36.7K | 36.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-11 | A | A | 18,360 | $0.00 | 18,360 | D | — | — | (F1) Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option | 2021-11-11 | A | A | 36,720 | $0.00 | 36,720 | D | $13.55 · — to 2029-11-10 | 36,720 Common Stock | (F3) This stock option vests in equal monthly installments over the three-year period beginning on November 11, 2021. |